Pharmacovigilance Benchmarking & Market Dynamics (2nd Ed.)

Report Overview

Staying current on market dynamics and trends in the pharma world is a tall order. ISR surveyed 100 decision-makers in the pharmacovigilance space to gather their insights regarding the market and where it’s heading. Survey respondents shared their experience regarding how their companies’ pharmacovigilance activities are split between processes, how much of their work is outsourced and to what types of providers, and both in-house and outsourced personnel locations.
When ISR gathers data on selection and performance, two audiences are typically in mind. The first audience is sponsor companies. We want to help decision-makers at sponsor organizations understand how peers in the industry select providers and how providers have performed for recent customers. The second audience is providers. We strive to assist providers in understanding how they are viewed through the eyes of their customers so they can better promote their strengths and improve areas where they may be falling short.

What you will learn:

Study Sponsors

• Insights on the current pharmacovigilance market and what it is expected to look like in the next three years
• Trends in technology use for pharmacovigilance activities, including approaches to social media and ways to make pharmacovigilance work less manual
• How decision-makers in the industry select providers and how providers have performed for recent customers

CROs, Pharmacovigilance Providers, and Software Providers

• Which pharmacovigilance/ drug safety activities are most prevalent, and which are most commonly outsourced
• The most critical capabilities customers are searching for when selecting a pharmacovigilance provider
• Which providers top the lists for perceived leadership, familiarity, proposal volume, and reported use of their pharmacovigilance services
• How your company’s performance is rated along a variety of attributes and how competitors perform along the same dimensions

Major Topics:

• Pharmacovigilance Market and Outsourcing Dynamics
• Provider Selection
• Provider Perceptions and Interactions
• Provider and Software Performance
• Trends in Pharmacovigilance
• Study Data